Clinical Trial Update: Study of Amiodarone Given Before Lung Surgery to Prevent Atrial Fibrillation After Lung Resection [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating amiodarone given before lung surgery to prevent atrial fibrillation after lung resection was terminated; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation
• Lung Cancer

Drugs mentioned

• Amiodarone (amiodarone)

Snippet

Sponsor: Beth Israel Deaconess Medical Center | Conditions: Atrial Fibrillation, Lung Cancer | Phase 3 | Status: TERMINATED | Results posted: 2017-04-28